Cost of treatment of childhood-onset systemic lupus erythematosus

Arthritis Care and Research

Volumn 55, Issue 2, 2006, Pages 184-188

  Brunner, Hermine I ^a   Sherrard, Tina M ^a   Klein Gitelman, Marisa S ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Children; Cost; Lupus; Systemic lupus erythomatosus

Indexed keywords

ARTICLE; CHILD; CHILD HEALTH QUESTIONNAIRE; CHILDHOOD DISEASE; CONTROLLED STUDY; DATA BASE; DAY HOSPITAL; DRUG COST; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEMODIALYSIS; HOSPITAL CARE; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

CHILD; COSTS AND COST ANALYSIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE;

EID: 33645921318     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.21845     Document Type: Article

References (20)

1. Clarke AE, Petri M, Manzi S, Isenberg DA, Gordon C, Senecal JL, et al, and the Tri-Nation Study Group. The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome. Rheumatology (Oxford) 2004;43:1016-24.
2. Yelin E. Cost of musculoskeletal diseases: impact of work disability and functional decline. J Rheumatol Suppl 2003;68:8-11.
3. Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001;40:37-47.
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
5. Brunner HI, Barron AC, Graham TB, Passo MH, Johnson AL, Lenihan J, et al. Effects of treatment on costs & health-related quality of life (HRQL) of children with polyarticular course juvenile rheumatoid arthritis (JRA) [abstract]. Arthritis Rheum 2004;50 Suppl 9:S686.
6. Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, et al. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 2004;51:458-64.
7. Landgraf J, Abetz L, Ware J. The CHQ user's manual. 1st ed. Boston: The Health Institute, New England Medical Center; 1996.
8. Petty RE, Cassidy JT. Systemic lupus erythematosus. In: Cassidy JT, Petty RE, editors. Pediatric rheumatology. Philadelphia: W.B. Saunders Company; 2001. p. 396-449.
9. Bishnoi A, Barron AC, Graham TB, Passo MH, Houk LJ, Mongey AB, et al. Long-term outcomes of childhood-onset systemic lupus erythematosus (cSLE) [abstract]. Arthritis Rheum 2004;50 Suppl 9:S533.
10. US Census Bureau. United States Census 2000. URL: www. census.gov.
11. Mok CC, Lee KW, Ho CT, Lau CS, Wong RW. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000;39:399-406.
12. Minden K, Niewerth M, Listing J, Biedermann T, Schontube M, Zink A. Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis 2004;63:836-42.
13. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
14. Allaire SH, DeNardo BS, Szer IS, Meenan RF, Schaller JG. The economic impacts of juvenile rheumatoid arthritis. J Rheumatol 1992;19:952-5.
15. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-72.
16. Rojas-Seirano J, Cardiel MH. Lupus patients in an emergency unit: causes of consultation, hospitalization and outcome: a cohort study. Lupus 2000;9:601-6.
17. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and health-care cost. Med Care 2005;43:521-30.
18. Nichol MB, Shi S, Knight TK, Wallace DJ, Weisman MH. Eligibility, utilization, and costs in a California Medicaid lupus population. Arthritis Rheum 2004;51:996-1003.
19. Clarke A. Economic impact of lupus. Am J Manag Care 2001;7 Suppl:S496-501.
20. Brunner H, Gladmann DD, Ibanez D, Urowitz MB, Silverman E. Difference in disease features between childhood-onset and adult systemic lupus erythematosus (SLE) [abstract]. Arthritis Rheum 2003;48 Suppl 9:S506.